Measurement properties of the Timed Up & Go test in patients with COPD
- PMID: 27165963
- PMCID: PMC5734421
- DOI: 10.1177/1479972316647178
Measurement properties of the Timed Up & Go test in patients with COPD
Abstract
We aimed to investigate the construct validity of the Timed Up & Go (TUG) test in chronic obstructive pulmonary disease (COPD), to identify characteristics related to an abnormal TUG time and to examine the responsiveness of the TUG to pulmonary rehabilitation (PR). TUG time was assessed before and after comprehensive PR in 500 COPD patients, and compared cross-sectionally in 100 non-COPD subjects. Physical health outcomes, mental health outcomes, symptom-related outcomes and multidimensional indices were assessed in COPD patients only. Good convergent and discriminant validity was demonstrated by fair-to-moderate correlation with physical health outcomes, symptom-related outcomes and multidimensional indices ( rs = 0.18-0.70) and by little correlation with mental health outcomes ( rs = 0.21-0.26). COPD patients had a worse TUG time than non-COPD subjects, demonstrating known-groups validity. A TUG time of 11.2 seconds had good sensitivity (0.75) and specificity (0.83) for identifying patients with a baseline 6-minute walk distance <350 m. TUG time improved after PR ( p < 0.0001) and a change of 0.9-1.4 seconds was identified as clinically important. The TUG is valid and responsive in COPD. An abnormal result is indicative of poor health outcomes. This simple test provides valuable information and can be adopted in clinical and research settings.
Keywords: Chronic obstructive pulmonary disease; outcome assessment (healthcare); rehabilitation.
Conflict of interest statement
Figures



Similar articles
-
Within-day test-retest reliability of the Timed Up & Go test in patients with advanced chronic organ failure.Arch Phys Med Rehabil. 2013 Nov;94(11):2131-8. doi: 10.1016/j.apmr.2013.03.024. Epub 2013 Apr 10. Arch Phys Med Rehabil. 2013. PMID: 23583345
-
Diagnostic ability of the Timed Up & Go test for balance impairment prediction in chronic obstructive pulmonary disease.J Thorac Dis. 2020 May;12(5):2406-2414. doi: 10.21037/jtd.2020.03.47. J Thorac Dis. 2020. PMID: 32642146 Free PMC article.
-
Role of the Timed Up and Go Test in Patients With Chronic Obstructive Pulmonary Disease.J Cardiopulm Rehabil Prev. 2016 Jan-Feb;36(1):49-55. doi: 10.1097/HCR.0000000000000143. J Cardiopulm Rehabil Prev. 2016. PMID: 26398326
-
Effects of a pulmonary rehabilitation program with balance training on patients with COPD.J Cardiopulm Rehabil Prev. 2015 Mar-Apr;35(2):154-8. doi: 10.1097/HCR.0000000000000097. J Cardiopulm Rehabil Prev. 2015. PMID: 25517104 Clinical Trial.
-
Progress in Characterizing Patient-Centered Outcomes in COPD, 2004-2014.Chronic Obstr Pulm Dis. 2014 May 6;1(1):17-22. doi: 10.15326/jcopdf.1.1.2014.0121. Chronic Obstr Pulm Dis. 2014. PMID: 28848807 Free PMC article. Review. No abstract available.
Cited by
-
Psychometric properties of performance-based measures of physical function administered via telehealth among people with chronic conditions: A systematic review.PLoS One. 2022 Sep 9;17(9):e0274349. doi: 10.1371/journal.pone.0274349. eCollection 2022. PLoS One. 2022. PMID: 36083879 Free PMC article.
-
Association Between the Results of the Timed Up-and-Go Test Adjusted for Disease Severity and Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease: a Pilot Study.Clinics (Sao Paulo). 2019 Nov 7;74:e930. doi: 10.6061/clinics/2019/e930. eCollection 2019. Clinics (Sao Paulo). 2019. PMID: 31721937 Free PMC article.
-
Rectus Femoris Cross-Sectional Area and Phase Angle asPredictors of 12-Month Mortality in Idiopathic Pulmonary Fibrosis Patients.Nutrients. 2023 Oct 22;15(20):4473. doi: 10.3390/nu15204473. Nutrients. 2023. PMID: 37892547 Free PMC article.
-
Towards Personalized Management of Sarcopenia in COPD.Int J Chron Obstruct Pulmon Dis. 2021 Jan 7;16:25-40. doi: 10.2147/COPD.S280540. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33442246 Free PMC article. Review.
-
Interindividual variability in response to protein and fish oil supplementation in older adults: a randomized controlled trial.J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):872-883. doi: 10.1002/jcsm.12936. Epub 2022 Feb 21. J Cachexia Sarcopenia Muscle. 2022. PMID: 35191215 Free PMC article. Clinical Trial.
References
-
- Jones SE, Kon SS, Canavan JL, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD. Thorax 2013; 68: 1015–1020. - PubMed
-
- Kon SS, Patel MS, Canavan JL, et al. Reliability and validity of 4-metre gait speed in COPD. Eur Respir J 2013; 42: 333–340. - PubMed
-
- Kon SS, Canavan JL, Nolan CM, et al. The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference. Eur Respir J 2014; 43: 1298–1305. - PubMed
-
- Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142–148. - PubMed
-
- Mesquita R, Janssen DJ, Wouters EF, et al. Within-day test-retest reliability of the timed up & go test in patients with advanced chronic organ failure. Arch Phys Med Rehabil 2013; 94: 2131–2138. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials